Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

Oncotarget. 2017 Jul 18;8(29):47239-47249. doi: 10.18632/oncotarget.17592.


Adipose tissue secretes a plethora of adipokines as evidenced by characterization of subcutaneous and visceral adipose tissue secretomes. However, adipose tissue composition and secretion pattern is depot and disease dependent, influencing the adipose tissue secretome. We investigated the secretome of cancer-associated adipose tissue (CAAT) explants from breast cancer patients and explored its role in breast cancer proliferation. CAAT proteins were identified by LC-MS/MS and human protein antibody arrays and stimulated proliferation of three breast cancer cell lines. Kinomics and transcriptomics of MCF-7 breast cancer cells treated with the secretome of CAAT revealed activation of Akt-, ERK- and JNK-pathways and differential expression of activator protein 1 (AP-1) and cAMP responsive element-binding protein (CREB) target genes. The cyclin-dependent kinase (CDK)4/6-inhibitor palbociclib significantly abrogated CAAT-enhanced breast cancer cell proliferation. Our work characterizes the specific breast CAAT protein secretome and reveals its pro-proliferative potency in breast cancer.

Keywords: adipose tissue; breast cancer; palbociclib; proliferation; secretome.

MeSH terms

  • Adipose Tissue / metabolism*
  • Adipose Tissue / pathology*
  • Antineoplastic Agents / pharmacology
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Female
  • Humans
  • Metabolomics* / methods
  • Paracrine Communication*
  • Piperazines / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Proteomics / methods
  • Pyridines / pharmacology
  • Transcription Factor AP-1 / metabolism


  • Antineoplastic Agents
  • Cyclic AMP Response Element-Binding Protein
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyridines
  • Transcription Factor AP-1
  • palbociclib